Senzime AB Company Description
Senzime AB (publ), a medical device company, develops, manufactures, and markets algorithm-powered patient monitoring systems to increase patient safety during and after surgery in Europe and the United States.
It offers TetraGraph, a quantitative neuromuscular transmission monitor, which supports neuromuscular blockade management from induction to recovery; and ExSpiron, a non-invasive monitoring system that uses bioelectrical impedance to measure the tissue’s opposition to carrying an alternating electrical current.
The company has a strategic connectivity and licensing agreement with Masimo to develop, manufacture, market, and distribute products that can connect to the Masimo Root patient monitoring system and related digital hub for data transmission to hospital electronic patient journals; license agreement with Fukuda Denshi Co. Ltd. to license TetraGraph technology; and license agreement with CoreSpiron (Henan) Co Ltd. to manufacture and sell ExSpiron system.
Senzime AB (publ) was incorporated in 1999 and is headquartered in Uppsala, Sweden.
Country | Sweden |
Founded | 1999 |
Industry | Medical Devices |
Sector | Healthcare |
Employees | 52 |
CEO | Philip Siberg |
Contact Details
Address: Ulls vAeg 41 Uppsala, 756 51 Sweden | |
Phone | 46 18 51 56 40 |
Website | senzime.com |
Stock Details
Ticker Symbol | SEZI |
Exchange | Nasdaq Stockholm |
Fiscal Year | January - December |
Reporting Currency | SEK |
ISIN Number | SE0002478776 |
SIC Code | 3845 |
Key Executives
Name | Position |
---|---|
Philip Siberg | Chief Executive Officer |
Slavoljub Grujicic | Chief Financial Officer |
Johanna Tulkki | Chief Operating Officer |
Rianne Lundqvist Waninge Ph.D. | Application Scientist |
Paula Treutiger | Head of Communication and Investor Relations |
Anders Selin | Executive Vice President of Sales |
Michael Noble | Vice President Global Marketing |
Anders Jacobson | Chief Innovation Officer |
Catrin Molund | Executive Vice President of Business Development |
Johanna Faris | Head of Q/RA/S |